Status report
Get it in writing
The official USPTO status record for IDACIO, serial 97295308, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
IDACIOSerial 97295308 · Principal Register
Live · Registered
Owner: Fresenius Kabi Deutschland GmbH
Class 005 - Pharmaceuticals
Filed Mar 04, 2022
Registered Nov 28, 2023
The record shows that the mark IDACIO is live and registered on the Principal Register, owned by Fresenius Kabi Deutschland GmbH, a German limited‑liability company. It covers “pharmaceutical preparations for the treatment of autoimmune diseases, illnesses, and conditions” in International Class 005, with a first use date of July 1 2023, so a similar name used for any pharmaceutical product in that therapeutic area would present the closest record‑based concern. The record does not give the owner control over every possible use of the word IDACIO outside those listed goods, and it does not extend to unrelated products or services. The most recent meaningful event is the registration confirmation on November 28 2023, which also serves as the current status date; no future deadline appears in the data. The prosecution history contains no oppositions, cancellations or other enforcement actions, so the supplied history shows none. I'd treat this as a meaningful concern if you plan a pharmaceutical brand in the same therapeutic space.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.